Methods for diagnosing a colorectal cancer (CRC) health state or change in CRC health state, or for diagnosing risk of developing CRC or the presence of CRC in a subject
US 10,697,969 In forceTerm ends Oct 11, 2027 · From the USPTO record
20-year base term ended Sep 12, 2026
Sep 12, 2006
Oct 11, 2027
Jun 30, 2020
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 12, 2006, when the earliest non-provisional application in its chain was filed (this one was filed Jun 24, 2016); a parent in its chain could not be resolved (the next row) | Sep 12, 2026 | USPTO record |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | USPTO record |
| Patent term adjustment | +394 days, USPTO patent term adjustment record | Oct 11, 2027 | USPTO record |
| Terminal disclaimer cap | None on record | no cap applied | USPTO record |
| Patent term extension | None on file | no change | USPTO record |
| Fee events | 1 of 1 maintenance fees paid | In force | USPTO record |
| Computed term end | The steps above, in order | Oct 11, 2027 | USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.